Frequently Asked Questions

As a non-US company, investors in the United States have utilized the Roche ADR program since 1992. Here are answers to some of the most frequently asked questions from investors:

General Questions

American Depositary Receipts (ADRs)

Download the Roche ADR Backgrounder for more information.

Investing in Roche

Contact Us

Share Information

Reasons to Invest

120+
Years of combined expertise in biotech, pharma, and diagnostics
72
New molecule entities in the pipeline
31
Years in a row of increased dividends